pulmonary tuberculosis

Showing NaN - NaN of 7

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis Trial in Worldwide (TBAJ-876, Pretomanid, Linezolid)

Not yet recruiting
  • Pulmonary TB
  • +2 more
  • Tbilisi, Georgia
  • +20 more
Sep 22, 2023

Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,

Active, not recruiting
  • Infections and Infestations
  • Pulmonary Tuberculosis
  • Tembisa, Gauteng, South Africa
  • +4 more
Sep 13, 2022

Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection Trial in Johannesburg (Isoniazid, Rifampicin, Ethambutol)

Recruiting
  • Tuberculosis
  • +2 more
  • Johannesburg, Gauteng, South Africa
    Tembisa Clinical Research Centre-The Aurum Institute
Jun 8, 2022

Tuberculosis, Pulmonary Tuberculosis Trial in Johannesburg (Pravastatin, Rifafour, Vitamin B6)

Recruiting
  • Tuberculosis
  • Pulmonary Tuberculosis
  • Johannesburg, Gauteng, South Africa
    PHRU Non-Network CRS
Oct 29, 2021

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis Trial in Belarus, South

Active, not recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +4 more
May 12, 2021

Pulmonary Tuberculosis Trial in South Africa, Tanzania (Moxifloxacin (M), Pretomid (Pa), Pyrazinamide (Z))

Completed
  • Pulmonary Tuberculosis
  • Moxifloxacin (M)
  • +3 more
  • Cape Town, South Africa
  • +7 more
May 16, 2018

Pulmonary Tuberculosis Trial in Worldwide (Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin)

Completed
  • Pulmonary Tuberculosis
  • Moxifloxacin, Ethambutol, Isoniazid, Pyrazinamide & Rifampicin
  • Beijing, China
  • +46 more
Feb 15, 2017